Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model
ConclusionsSalmonella typhimurium A1-R has potential future clinical application to overcome drug resistance in cervical cancer.
Source: Archives of Gynecology and Obstetrics - Category: OBGYN Source Type: research
More News: Cancer | Cancer & Oncology | Cancer of the Uterus | Cervical Cancer | OBGYN | Salmonella | Study